Moran will be eligible to receive an annual bonus, which is targeted at up to 40% of his base salary but which may be adjusted by the Board based on his individual performance and the Companys performance as a whole
The SURMOUNT-4 trial showed that stopping treatment led to weight regain, while continued use maintained and even increased weight loss (25.3% total at 88 weeks)
The first employed anti-cancer drugs were poorly-selective (killing rapidly proliferating cells) and with high-spectrum (effective against most tumors)
Residual TFA: Trifluoroacetic acid is a leftover from synthesis
By simultaneously aiming at GLP-1, GIP, and glucagon receptors, these drugs, such as retatrutide, deliver significantly greater efficacy than current therapies, expanding the addressable patient base
Its being evaluated for weight loss and metabolic health but is not available to the public yet